Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism

Free Radical Biology and Medicine

Volumn 47, Issue 4, 2009, Pages 424-430

  Valdés Arzate, Argelia ^a   Luna, Armando ^a   Bucio, Leticia ^a   Licona, Cynthia ^a   Clemens, Dahn L ^b   Souza, Verónica ^a   Hernandez, Elizabeth ^a   Kershenobich, David ^c   Gutiérrez Ruiz, María Concepción ^a   Gómez Quiroz, Luis Enrique ^a  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Alcoholic liver disease; Cytochrome P450 2E1; Ethanol; Free radicals; HepG2; Oxidative stress

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME P450 2E1; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; PEROXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SN 50; WORTMANNIN;

ALCOHOL METABOLISM; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL DAMAGE; CELL PROTECTION; CELL STRAIN HEPG2; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL; MITOGENESIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANDROSTADIENES; CATALASE; CELL EXTRACTS; CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; CYTOPROTECTION; ETHANOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; LIPID PEROXIDATION; LIVER DISEASES, ALCOHOLIC; NEUROPHYSINS; NF-KAPPA B; OXIDATIVE STRESS; PEPTIDES; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TRANSFECTION; TRANSGENES; VASOPRESSINS;

EID: 67650034524     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.05.014     Document Type: Article

References (37)

1. Zakhari S., and Li T.K. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 46 (2007) 2032-2039
2. Nagata K., Suzuki H., and Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J. Toxicol. Sci. 32 (2007) 453-468
3. Lu Y., and Cederbaum A.I. CYP2E1 and oxidative liver injury by alcohol. Free Radic. Biol. Med. 44 (2007) 723-738
4. Wu D., and Cederbaum A.I. Oxidative stress-mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicol. Appl. Pharmacol. 207 (2005) 70-76
5. Albano E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 65 (2006) 278-290
6. Garcia-Ruiz C., and Fernandez-Checa J.C. Redox regulation of hepatocyte apoptosis. J. Gastroenterol. Hepatol. 22 Suppl. 1 (2007) S38-42
7. 2-induced toxicity in bile duct epithelial cells. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 147 (2007) 324-330
8. Suzuki A., Hayashida M., Kawano H., Sugimoto K., Nakano T., and Shiraki K. Hepatocyte growth factor promotes cell survival from Fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32 (2000) 796-802
9. Carmona-Cuenca I., Herrera B., Ventura J.J., Roncero C., Fernandez M., and Fabregat I. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death. J. Cell. Physiol. 207 (2006) 322-330
10. Furge K.A., Zhang Y.W., and Vande Woude G.F. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 19 (2000) 5582-5589
11. Zarnegar R., and Michalopoulos G.K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 129 (1995) 1177-1180
12. Huh C.G., Factor V.M., Sanchez A., Uchida K., Conner E.A., and Thorgeirsson S.S. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc. Natl. Acad. Sci. USA 101 (2004) 4477-4482
13. Xiao G.H., Jeffers M., Bellacosa A., Mitsuuchi Y., Vande Woude G.F., and Testa J.R. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc. Natl. Acad. Sci. USA 98 (2001) 247-252
14. Schulze-Bergkamen H., Brenner D., Krueger A., Suess D., Fas S.C., Frey C.R., Dax A., Zink D., Buchler P., Muller M., and Krammer P.H. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 39 (2004) 645-654
15. Okada M., Sugita K., Inukai T., Goi K., Kagami K., Kawasaki K., and Nakazawa S. Hepatocyte growth factor protects small airway epithelial cells from apoptosis induced by tumor necrosis factor-alpha or oxidative stress. Pediatr. Res. 56 (2004) 336-344
16. Li H., Jiang T., Lin Y., Zhao Z., and Zhang N. HGF protects rat mesangial cells from high-glucose-mediated oxidative stress. Am. J. Nephrol. 26 (2006) 519-530
17. Takami T., Kaposi-Novak P., Uchida K., Gomez-Quiroz L.E., Conner E.A., Factor V.M., and Thorgeirsson S.S. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Res. 67 (2007) 9844-9851
18. Donohue T.M., Osna N.A., and Clemens D.L. Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity. Int. J. Biochem. Cell Biol. 38 (2006) 92-101
19. Roman J., Gimenez A., Lluis J.M., Gasso M., Rubio M., Caballeria J., Pares A., Rodes J., and Fernandez-Checa J.C. Enhanced DNA binding and activation of transcription factors NF-kappa B and AP-1 by acetaldehyde in HEPG2 cells. J. Biol. Chem. 275 (2000) 14684-14690
20. Nakagawa T., Sawada M., Gonzalez F.J., Yokoi T., and Kamataki T. Stable expression of human CYP2E1 in Chinese hamster cells: high sensitivity to N,N-dimethylnitrosamine in cytotoxicity testing. Mutat. Res. 360 (1996) 181-186
21. Fariss M.W., and Reed D.J. High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Methods Enzymol. 143 (1987) 101-109
22. Buege J., and Aust S. Microsomal lipid peroxidation. Methods Enzymol. 52 (1978) 302-310
23. Clemens D.L., Forman A., Jerrells T.R., Sorrell M.F., and Tuma D.J. Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology 35 (2002) 1196-1204
24. Ozaki M., Haga S., Zhang H.Q., Irani K., and Suzuki S. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 10 (2003) 508-515
25. 2+ mobilization in rat hepatocytes. Alcohol Clin. Exp. Res. 20 (1996) 330A-334A
26. Fernandez-Checa J.C., and Kaplowitz N. Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicol. Appl. Pharmacol. 204 (2005) 263-273
27. Ronis M., Lindros K., and Ingelman-Sundberg M. The CYP2E1 family. In: Ionides C. (Ed). Cytochromes P450: Metabolic and Toxicological Aspects (1996), CRC Press, Boca Raton, Fla. 211-239
28. Girre C., Lucas D., Hispard E., Menez C., Dally S., and Menez J.F. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem. Pharmacol. 47 (1994) 1503-1508
29. Osna N.A., Clemens D.L., and Donohue Jr. T.M. Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol. Biochem. Pharmacol. 66 (2003) 697-710
30. Venugopal S.K., Chen J., Zhang Y., Clemens D., Follenzi A., and Zern M.A. Role of MAPK phosphatase-1 in sustained activation of JNK during ethanol-induced apoptosis in hepatocyte-like VL-17A cells. J. Biol. Chem. 282 (2007) 31900-31908
31. Kaposi-Novak P., Lee J.S., Gomez-Quiroz L., Coulouarn C., Factor V.M., and Thorgeirsson S.S. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J. Clin. Invest. 116 (2006) 1582-1595
32. Fan S., Gao M., Meng Q., Laterra J.J., Symons M.H., Coniglio S., Pestell R.G., Goldberg I.D., and Rosen E.M. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24 (2005) 1749-1766
33. Yang H., Magilnick N., Xia M., and Lu S.C. Effects of hepatocyte growth factor on glutathione synthesis, growth, and apoptosis is cell density-dependent. Exp. Cell Res. 314 (2008) 398-412
34. Imose M., Nagaki M., Naiki T., Osawa Y., Brenner D.A., Asano T., Hayashi H., Kato T., and Moriwaki H. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice. Liver Int. 23 (2003) 386-396
35. Lu Y., Zhou J., Xu C., Lin H., Xiao J., Wang Z., and Yang B. JAK/STAT and PI3K/AKT pathways form a mutual transactivation loop and afford resistance to oxidative stress-induced apoptosis in cardiomyocytes. Cell Physiol. Biochem. 21 (2008) 305-314
36. Tsuboi S. Elevation of glutathione level in rat hepatocytes by hepatocyte growth factor via induction of gamma-glutamylcysteine synthetase. J. Biochem. 126 (1999) 815-820
37. Gomez-Quiroz L.E., Factor V.M., Kaposi-Novak P., Coulouarn C., Conner E.A., and Thorgeirsson S.S. Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis. J. Biol. Chem. 283 (2008) 14581-14589